Avexima opens Research Center in Skolkovo Technopark

The official opening ceremony of the Avexima Research and Development (R&D) Center was held at the Skolkovo Technopark. The Center will focus on developing modern drugs and enhancing the company's production capabilities.

The R&D Center has been accredited as a Shared Use Center of the Skolkovo Technopark and is also geared towards supporting and providing services for young biomedical companies, primarily participants of the Skolkovo project.

The Skolkovo laboratory complex is the first stage in a large-scale program to develop the scientific research direction of Avexima The next stage is the construction of the largest pharmaceutical industrial and logistics complex at the Yesipovo»Technopark, where all the company's research facilities will be consolidated with the aim of boosting its potential in the pharmaceutical development of new drugs.

According to Elena Tkachenko, General Director of Avexima JSC, the new laboratory, equipped with state-of-the-art technology, will be another step towards implementing the company's strategic goal to create a portfolio of modern domestically manufactured drugs.

«We believe in the future of Russia's pharmaceutical industry. Creating modern, high-quality Russian-made drugs is the top priority of Avexima, - emphasized Elena Tkachenko.

«Today, it is impossible to be effective without constant development»,  -  commented Igor Onokhov, Head of the Development and Project Implementation Department at Avexima JSC.  - «It is obvious that in the modern world, development is of defining importance. Investment in R&D is a key success factor for a modern pharmaceutical company. Having our own Research Center with highly qualified personnel will allow our company to stand alongside the leading companies in the pharmaceutical industry. And the fact that this center is opening precisely in the Skolkovo Technopark once again emphasizes our commitment to innovation and our aspiration to maximally utilize the existing potential of biomedical project innovations»

Avexima is a full-cycle Russian pharmaceutical company. Production sites are located in Moscow, Sverdlovsk, and Kemerovo regions. The product portfolio includes over 100 drug names, including antiviral, immunological, and antibacterial drugs. The company is working on the construction of one of the largest pharmaceutical production and logistics centers at the Yesipovo Industrial Park in the Moscow Region.